Kielgast, U., Krarup, T., Holst, J
A proof-of-concept, open-label trial of weekly exenatide (2 mg, 48 weeks, 50 patients) showed an advantage in the unified multiple system atrophy rating scale (UMSARS, parts I and II combined score) at 48 weeks compared with best medically treated participants, but no difference in more objective secondary measures or biomarkers (neurofilament light chain [NfL], CSF -synuclein oligomers) (165)
Lunch: Greek salad with grilled chicken, lettuce, tomatoes, cucumber, and olives
Actor Ram Kapoor, producers Boney Kapoor and Sajid Nadiadwala, and rapper Badshaah are the latest to join the league
Reduced plasma free fatty acid availability during exercise: effect on gene expression